Cancer agents show first-line potential.

摘要

Clinical studies have pointed to various agents as potential new first-line treatments for patients with cancer. At the 43rd annual meeting of the American Society of Clinical Oncology, held here in June, researchers presented findings from trials evaluating the safety and efficacy of some of these, therapies.